Not a Lexis Advance subscriber? Try it out for free.

Dexcowin Global, Inc. v. Aribex, Inc.

United States District Court for the Central District of California

June 29, 2017, Decided; June 29, 2017, Filed

CV 16-143-GW(AGRx)

Opinion

CIVIL MINUTES - GENERAL

PROCEEDINGS: MOTION FOR RECONSIDERATION BY DEXCOWIN GLOBAL, INC. AND DEXCOWIN CO. LTD. [170];

PRETRIAL CONFERENCE

The Court's Tentative Ruling as to Dexcowin's Motion for Reconsideration is circulated. Court hears oral argument. For reasons stated on the record, Plaintiff's Motion is TAKEN UNDER SUBMISSION. Court to issue ruling.

Court and counsel confer re scheduling. The Jury Trial set for July 11, 2017, is ADVANCED to July 10, 2017 at 11:00 a.m.

The Court's Tentative Rulings as to Motions in Limine is circulated and attached hereto. Court hears argument and rules as follows:

Plaintiff Dexcowin Global, Inc. and Dexcowin Co. Ltd.'s Motions in Limine:

No. 1 to Preclude Aribex from Offering Irrelevant, Confusing, and Prejudicial Evidence or Testimony [184] is GRANTED IN PART and DENIED IN PART;

No. 2 to Preclude Aribex from Offering the Testimony of Scott Hadden [186] is DENIED;

No. 3 to Preclude Aribex from Offering the Testimony of Martin Hillman [187] [*2]  is DENIED;

No. 4 to Exclude Certain Damages Testimony of Dr. Charles Mahla [207] is TAKEN UNDER SUBMISSION. Dr. Mahla will be deposed prior to trial with Defendants to pay costs;

No. 5 to Exclude the Expert Testimony of Dr. Steven Smith [208] is DENIED.

Defendant/Counter-claimant Aribex's Motions in Limine:

No. 1 to Exclude Testimony of Deung Ro-lee and Any Other Evidence on Product Development [176] is continued to July 3, 2017. Copies of documents will be produced by noon on June 30, 2017;

No. 2 to Exclude Reference to IMS2000 [177] is continued to July 3, 2017. Copies of documents will be produced by noon on June 30, 2017;

Read The Full CaseNot a Lexis Advance subscriber? Try it out for free.

Full case includes Shepard's, Headnotes, Legal Analytics from Lex Machina, and more.

2017 U.S. Dist. LEXIS 181959 *

Dexcowin Global, Inc. v. Aribex, Inc.

Prior History: Dexcowin Global, Inc. v. Aribex, Inc., 2017 U.S. Dist. LEXIS 182033 (C.D. Cal., June 1, 2017)

CORE TERMS

patented, prior art, products, x-ray, invention, Reply, battery, infringement, features, license, royalty, personal knowledge, documents, invalidity, combine, references, deposition, testifying, testing, offering, damages, sales, lost profits, noninfringement, portable, summary judgment, subspecialties, customer, handheld, Dental